首页> 中文期刊> 《外科研究与新技术》 >Expression of cancer-testis antigen CT10 gene mRNA in hepatocellular carcinoma and prediction of HLA - A2 restricted CTL epitopes of CT10

Expression of cancer-testis antigen CT10 gene mRNA in hepatocellular carcinoma and prediction of HLA - A2 restricted CTL epitopes of CT10

         

摘要

Objective To investigate the expression of cancer-testis antigen CT10 gene mRNA in hepatocellular carcinoma and predict the HLA-A2-restricted CTL epitopes of CT10. Methods The expression of CT10 mRNA was detected by using RT - PCR in HCC tissues and the corresponding adjacent non-HCC tissues from 45 HCC patients, among those 3 samples selected randomly from CT10 PCR positive products were sequenced. HLA - A2-restricted CTL epitopes of CT10 was predicted by peptide supermotif prediction combined with quantitative motif. Results CT10 mRNA was detectable in 19/45 (42. 2%) of HCC samples, while the corresponding adjacent non-HCC tissue were all negative in expression of CT10 mRNA. In addition, The DNA sequence confirmed that the RT- PCR products were truly CT10 cDNA. No June 2003 Vol12 No2 relationship was found between the expression of CT10 and demographic and clinical features such as age, sex, tumor size, degree of tumor differentiation, serum α-fetoprotein level and infection of hepatitis B virus or

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号